| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |